Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor α Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience by Pabla, Baldeep S., Alex Wiles, C., Slaughter, James C., Scoville, Elizabeth A., Dalal, Robin L., Beaulieu, Dawn B., Schwartz, David A., Horst, Sara N.

Get full text

Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease by Wiles, C Alex, Shah, Nisha B, Bell, Jake, Pabla, Baldeep S, Scoville, Elizabeth A, Dalal, Robin L, Beaulieu, Dawn B, Schwartz, David A, Horst, Sara N

Get full text

Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor [alpha] Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience by Pabla, Baldeep S, Alex Wiles, C, Slaughter, James C, Scoville, Elizabeth A, Dalal, Robin L, Beaulieu, Dawn B, Schwartz, David A

Get full text

A Mathematical Model of Calcium and cAMP Signaling in Pulmonary Microvascular Endothelial Cells by Webb, Kristal J, Wiles, C Alex, Annamdevula, Naga, Sweat, Rachel, Britain, Andrea L, Phan, Anh‐Vu, Townsley, Mary I, Leavesley, Silas J, Rich, Thomas C

Get full text

Clinical indicators for diabetic eyecare delivered by optometrists in Australia: a Delphi study by Gyawali, Rajendra, Toomey, Melinda, Stapleton, Fiona, Ho, Kam Chun, Keay, Lisa, Pye, David C, Katalinic, Paula, Liew, Gerald, Hsing, Yan Inez, Ramke, Jacqueline, Gentle, Alex, Webber, Ann L, Schmid, Katrina L, Bentley, Sharon, Hibbert, Peter, Wiles, Louise, Jalbert, Isabelle

Get full text